NASDAQ, COLL End of Day and Historical Stock Data [Collegium Pharma]

The worlds #1 website for end of day & historical stock data

wide range of exchanges, data formats, tools and services

APINEW HISTORICAL DATA SYMBOL LISTS MEMBERSHIP REGISTER LOG IN

NASDAQ, COLL:

05 Sep 2025

LAST: 38.32	CHANGE: 0.91	OPEN: 39.23	HIGH: 39.56	ASK: 9.80	VOLUME: 470K
LAST: 38.32	CHG(%): 2.32	PREV: 39.23	LOW: 38.18	BID: 16.72

CHART

Period:

RECENT END OF DAY PRICES

Date	Open	High	Low	Close	Volume
05 Sep 25	39.23	39.56	38.18	38.32	470K
04 Sep 25	39.58	39.61	38.72	39.23	304.9K
03 Sep 25	39.06	39.67	38.83	39.59	550.4K
02 Sep 25	38.77	39.78	38.67	39.16	556.1K
29 Aug 25	38.38	38.86	38.00	38.80	520.6K
28 Aug 25	38.99	38.99	38.15	38.35	316.3K
27 Aug 25	38.29	39.10	38.29	38.79	241.6K
26 Aug 25	38.93	39.06	38.29	38.58	461.1K
25 Aug 25	39.00	39.14	38.41	38.77	423.3K
22 Aug 25	39.84	39.95	38.81	39.11	447.8K

COMPANY PROFILE

Name:
About:	Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Sector:	Healthcare
Address:	100 Technology Center Drive, Stoughton, MA, United States, 02072
Website:	https://www.collegiumpharma.com
CUSIP:	19459J104
CIK:	0001267565
ISIN:	US19459J1043
FIGI:	BBG000N7LPW4
LEI:	54930049FXZMTLW8D496

SYMBOL HISTORY

Purchase End of Day History
for this symbol from Jan 01, 0001

Purchase Intraday History
for this symbol from Jan 01, 0001

Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

Exchange:

Format:

Period:

Zip file

Symbol:

Start Date:

End Date:

FUNDAMENTALS

P/E Ratio:	35.50
Price to Book:	5.11
Price to Sales:	1.68
EBITDA:	375.76M
Shares:	31.5M
Market Cap:	1.207B

TECHNICAL INDICATORS

MA5:	39.02
MA10:	38.87
MA20:	38.21
MA50:	34.04
MA100:	31.39
MA200:	30.73
STO14:	29.74
RSI14:	54.14
WPR14:	-64.80
MTM14:	0.13
ROC14:	0.00
ATR:	0.97
Week High:	39.78
Week Low:	38.00
Month High:	39.95
Month Low:	29.70
Year High:	42.29
Year Low:	23.23
Volatility:	41.52